Literature DB >> 65561

A new type of penicillin resistance of Staphylococcus aureus.

L D Sabath, N Wheeler, M Laverdiere, D Blazevic, B J Wilkinson.   

Abstract

Penicillin--"tolerant" Staphylococcus aureus strains are resistant to the lethal action of penicillins, but are inhibited by normal (low) concentrations. They are deficient in autolytic enzyme activity which appears to be necessary for bacteriolysis and the lethal action of penicillins. This "deficiency" is caused by a large excess of an inhibitor of autolysin. Seven such tolerant strains have been isolated from blood, bone, or sputum of patients who responded poorly to penicillin treatment of endocarditis, osteomyelitis, or staphylococcal pneumonia. These isolates were of different phage-types, and most showed cross-tolerance to the killing action of cephalosporins or vancomycin, antibiotics to which they were sensitive (inhibited). They were killed at normal rates by gentamicin, cycloserine, and rifampicin. Population analysis indicated that the proportion of tolerant organisms within a resistant strain is 7% or less; their ability to inhibit autolytic activity within their own and neighbouring cells appears to account for the net decreased autolytic activity of the entire strain; 44% of the bacteraemic strains studied showed penicillin tolerance. Tolerance is thus a common, clinically important form of penicillin resistance, that differs from previously described forms of pencillin resistance, that due to beta-lactamase, and that due to "intrinsic" (e.g., methicillin resistance) mechanisms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 65561     DOI: 10.1016/s0140-6736(77)91941-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  94 in total

1.  Morphological and physiological study of autolytic-defective Streptococcus faecium strains.

Authors:  D L Shungu; J B Cornett; G D Shockman
Journal:  J Bacteriol       Date:  1979-05       Impact factor: 3.490

2.  Quantitative assessment of bactericidal activities of beta-lactam antibiotics by agar plate method.

Authors:  G Masuda; S Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

3.  The response of Staphylococcus aureus to benzylpenicillin.

Authors:  T S Elliott; D Greenwood; F G Rodgers; F O'Grady
Journal:  Br J Exp Pathol       Date:  1979-02

4.  Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.

Authors:  E Yourassowsky; M P Van der Linden; F Crokaert
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Antibacterial properties of alafosfalin combined with cephalexin.

Authors:  F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; W J Lloyd; L J Nisbet; P S Ringrose; D Westmacott
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

6.  Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli.

Authors:  A S Bayer; A W Chow; J O Morrison; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  Deficient autolytic enzyme activity in antibiotic-tolerant lactobacilli.

Authors:  K S Kim; J O Morrison; A S Bayer
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

8.  Lack of reproducibility of macrodilution MBCs for Staphylococcus aureus.

Authors:  L L Pelletier
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

9.  Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice.

Authors:  W H Goessens; P Fontijne; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

10.  Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci.

Authors:  R M Blumenthal; R Raeder; C D Takemoto; E H Freimer
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.